Secular Trends in Outcomes for Fanconi Anemia Patients Who Receive Transplants: Implications for Future Studies
Open Access
- 30 September 2005
- journal article
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 11 (9) , 672-679
- https://doi.org/10.1016/j.bbmt.2005.05.007
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Risk of head and neck squamous cell cancer and death in patients with Fanconi anemia who did and did not receive transplantsBlood, 2005
- Acute graft-versus-host disease in patients with Fanconi anemia or acquired aplastic anemia undergoing bone marrow transplantation from HLA-identical sibling donors: risk factors and influence on outcomeBlood, 2004
- Low Risk of Graft-Versus-Host Disease With Transplantation of CD34 Selected Peripheral Blood Progenitor Cells From Alternative Donors for Fanconi AnemiaJournal of Pediatric Hematology/Oncology, 2003
- Cancer incidence in persons with Fanconi anemiaBlood, 2003
- The Fanconi anaemia/BRCA pathwayNature Reviews Cancer, 2003
- Unrelated cord blood transplantion in a Fanconi anemia patient using fludarabine-based conditioningBone Marrow Transplantation, 2001
- Stem cell transplantation for the treatment of Fanconi anaemia using a fludarabine-based cytoreductive regimen and T-cell-depleted related HLA-mismatched peripheral blood stem cell graftsBritish Journal of Haematology, 2000
- Bone marrow transplantation for patients with Fanconi anemia: reduced doses of cyclophosphamide without irradiation as conditioningBone Marrow Transplantation, 1999
- A fludarabine-based protocol for bone marrow transplantation in Fanconi’s anemiaBone Marrow Transplantation, 1997
- Malignancies after marrow transplantation for aplastic anemia and fanconi anemia: a joint Seattle and Paris analysis of results in 700 patientsBlood, 1996